Key takeaways:
In November 2024, the FDA issued a drug recall affecting 15 million over-the-counter pain relief patches. The recalled patches are used for pain relief and contain ingredients such as lidocaine, camphor, and menthol. These products were sold throughout the U.S.
The FDA found that a drug manufacturing facility in New Delhi, India, owned by Unexo Life Sciences, wasn’t following Current Good Manufacturing Practice (cGMP) regulations. This could lead to the production of medication patches that aren’t up to FDA standards in both quality and safety.
If you have a patch that’s been recalled, don’t use it. Even if it’s worked for you in the past, it may not be safe. A healthcare professional can help you find an alternative.
In November 2024, the FDA issued a drug recall affecting 15 million medicated pain patches. The recalled patches are used for pain relief and are sold over the counter (OTC). They contain ingredients such as lidocaine, camphor, and menthol — among others.
A drug recall is when a medication product is removed from the market. There can be several reasons for a drug recall, including contamination with potentially harmful chemicals, misleading information on the medication label, or a mechanical issue with the product. About 4,500 medications and medical devices are recalled each year.
Here, we’ll cover key considerations about the OTC pain relief patch recall, and what to do if your product is affected.
A company called Unexo Life Sciences manufactures several medication patch products. One of Unexo’s drug manufacturing facilities in New Delhi, India was flagged by the FDA for not following Current Good Manufacturing Practice (cGMP) regulations.
Drug manufacturing facilities registered with the FDA are required to comply with cGMP regulations to ensure they’re creating products that are safe and high quality. If the FDA finds that a facility isn’t following these regulations, the agency may recommend that the company recall (remove) their medications from the U.S. market. This can be temporary or permanent.
The FDA listed several ways Unexo wasn’t following cGMP regulations, including issues with:
Quality assurance over the final drug products
Documentation for the products they produce
Data showing that their products were tested appropriately prior to entering the market
Control over computer systems, so that only specific personnel can access certain documents and records
Cleanliness and sanitization of equipment
In short, the FDA doesn’t believe that the manufacturing facility in New Delhi is ensuring the safety or quality of the medication patches being sold in the U.S. For this reason, the FDA recommended that Unexo recall products produced at this facility, and Unexo complied.
Eleven pain patch products were affected by the recall. These products were distributed throughout the U.S. The names of the patch products are below:
Absorbine Jr. Extra Large Back Patch (menthol 5%)
Absorbine Jr. Ultra Strength Pain Patch (menthol 6.5%)
Absorbine Pain Relieving Knee Patch (camphor 7% / menthol 7%)
Theracare Maximum Strength Pain Relief (lidocaine 4%)
Theracare Cold Hot Medicated Patch (menthol 5%)
HealthWise Period Patch Menstrual Pain Relief (menthol 10%)
Equate Maximum Strength Lidocaine Pain Relieving Patch (lidocaine 4%)
Lilas Feminine Pain Relief Patch (menthol 10%)
JR Watkins Cooling Pain Relief Patches (menthol 7.5%)
Cheeky Bonsai Pain Relief Patches (menthol 10%)
Parche Leon Pain Relieving Hot Patch (camphor 3% / menthol 1.25% / capsaicin 0.025%)
Why drugs are recalled: Learn more about the top reasons why drugs are recalled, plus steps you should take if you’re affected by a recall.
Recalls 101: If a medical product has an issue that can potentially cause harm to the public, it may be recalled. Read about how FDA recalls work.
Lidocaine patches: Learn about these patches for pain relief and what products are available OTC versus prescription-only.
Keep in mind that this patch recall wasn’t announced in a formal FDA press release. Rather, the recall is detailed on the FDA website in an “enforcement report.” FDA Enforcement Reports contain information about drug recalls. Below, you can find the universal product code (UPC) and the number of patches recalled for each affected product.
Product name | Universal product code | Number of patches recalled |
---|---|---|
Absorbine Jr. Extra Large Back Patch (menthol 5%) | 8 89476 41218 6 | Close to 7 million |
Absorbine Jr. Ultra Strength Pain Patch (menthol 6.5%) | 8 89476 41318 3 | Close to 5 million |
Absorbine Jr. Pain Relieving Knee Patch (camphor 7% / menthol 7%) | 8 89476 41251 3 | Close to 1 million |
Lilas Feminine Pain Relief Patch (menthol 10%) | 7 87099 48212 1 | About 360,000 |
Theracare Maximum Strength Pain Relief (lidocaine 4%) | 8 45717 00878 5 | About 450,000 |
Theracare Cold Hot Medicated Patch (menthol 5%) | 8 45717 00818 1 | Close to 300,000 |
HealthWise Period Patch Menstrual Pain Relief (menthol 10%) | 8 45717 01072 6 | About 10,000 |
Equate Maximum Strength Lidocaine Pain Relieving Patch (lidocaine 4%) | 6 81131 07127 7 | About 1 million |
JR Watkins Cooling Pain Relief Patches (menthol 7.5%) | 8 56294 00878 5 | About 10,000 |
Cheeky Bonsai Pain Relief Patches (menthol 10%) | 8 60006 57564 9 | About 18,000 |
Parche Leon Pain Relieving Hot Patch (camphor 3% / menthol 1.25% / capsaicin 0.025%) | 8 59424 00433 6 | Close to 30,000 |
If you have a patch that’s been recalled, don’t use it. Even if it’s worked for you in the past, it may not be safe.
If you think you’ve experienced side effects from one of these patches, or you notice quality concerns, you can report the issue to the FDA. It’s also a good idea to check in with a healthcare professional so they can assess whether you need any further assistance or treatment.
Keep in mind that other pain patches are available that haven’t been recalled. Some are available OTC. Examples include:
Lidocaine 4% / menthol 1% patches (Icy Hot Max)
Menthol 5% (Icy Hot Original)
Lidocaine 4% (Salonpas Pain Relieving Gel-Patch)
Camphor 3.1% / menthol 6.0% / methyl salicylate 10.0% (Equate Medicated Pain Relief Patches)
Several other brand names are also available. Your pharmacist can help you find an OTC patch that closely matches what you were previously using. Prescription lidocaine patches are also available, such as lidocaine 5% (Lidoderm) and lidocaine 1.8% (ZTlido). Talk to your prescriber about whether one of these alternatives is a good option for you.
In some cases, you may be able to request a refund for your product. So ask the store or online retailer you bought it from about how they handle drug recalls.
Several resources are available to help you stay informed about drug recalls. You can also check for updates to this particular recall. Some options from the FDA include:
Enforcement Reports (which are produced weekly)
FDA recalls account on X (formerly known as Twitter)
Another option is to sign up to get emails from the FDA, which often contain information about recalls.
In November 2024, certain over-the-counter pain relief patches were recalled. These products were produced at a manufacturing facility in New Delhi, India owned by Unexo Life Sciences.
The recall was due to issues with quality control. The FDA found that the facility didn’t follow Current Good Manufacturing Practice (cGMP) regulations, resulting in products that aren’t up to FDA standards. If you use a patch product that’s affected by this recall, it’s wise to stop using it. Ask your prescriber or pharmacist to help you find an alternative.
Absorbine Jr., LLC. (2024). Absorbine Jr. extra large back patch, menthol 5%, 1 extra large patch per box [package insert].
Absorbine Jr., LLC. (2024). Absorbine Jr pain relieving knee patch, camphor 7%, menthol 7%, packaged in 1 patch (UPC 8 89476 41251 3) and b) 6 patches (UPC 8 89476 41306 0) [package insert].
Absorbine Jr., LLC. (2024). Absorbine Jr ultra strength pain patch, menthol 6.5%, 1 patch per box [package insert].
Cheeky Bonsai. (2024). Cheeky bonsai pain relief patches, menthol 10%, 4 patches per box [package insert].
J.R. Watkins, LLC. (2024). Jr watkins cooling pain relief patches, menthol 7.5%, 5 patches per box [package insert].
Lilas Wellness, Inc. (2024). Lilas feminine pain relief patch, menthol 10%, a) 5 patches per box (UPC 7 87099 48212 1) and 10 patches per box (UPC 7 87099 48211 4) [package insert].
Miller, E. (2023). Recalls. Drugwatch.
Pharmadel LLC. (2024). Parche leon pain relieving hot patch, camphor 3%, menthol 1.25%, capsaicin 0.025%, 6 patches per box [package insert].
U.S. Food and Drug Administration. (n.d.). Enforcement report.
U.S. Food and Drug Administration. (n.d.). MedWatch online voluntary reporting form.
U.S. Food and Drug Administration. (2020). Get email updates.
U.S. Food and Drug Administration. (2024). Enforcement reports.
U.S. Food and Drug Administration. (2024). Enforcement report: 95595.
U.S. Food and Drug Administration. (2024). Facts about the current good manufacturing practice (CGMP).
U.S. Food and Drug Administration. (2024). Recalls, market withdrawals, and safety alerts.
U.S. Food and Drug Administration. (2024). Warning letter: Unexo Lifesciences, Private Limited.
Veridian Healthcare, LLC. (2024). HealthWise period patch menstrual pain relief, menthol 10%, 10 patches per box [package insert].
Veridian Healthcare, LLC. (2024). Theracare cold hot medicated patch, menthol 5%, 5 patches per box [package insert].
Veridian Healthcare, LLC. (2024). Theracare maximum strength pain relief 4% lidocaine patch, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6) [package insert].
Walmart Inc. (2024). Equate maximum strength lidocaine pain relieving patch lidocaine 4% topical anesthetic, 6 patches per box patches, lidocaine 4% [package insert].